Mercado mundial del vitíligo: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado

En los últimos años, se prevé que el mercado del vitíligo crezca rápidamente durante el período de pronóstico. El vitíligo es una de las 24 enfermedades de la piel enumeradas por la Academia Estadounidense de Dermatología de Enfermedades de la Piel. En 2013, más de 150.000 estadounidenses de todas las edades fueron tratados por vitíligo, a un costo de aproximadamente USD 328 por paciente, tres veces más que la rosácea y el doble que el acné. El vitíligo es un trastorno de la piel en el que la pigmentación de la piel se pierde en parches. En todo el mundo, el vitíligo afecta al 0,2 por ciento al 1 por ciento de la población. El vitíligo afecta a cualquier parte del cuerpo cuando el color natural de la piel se pierde debido a la falta de melanina en la piel.

Data Bridge Market Research analiza que el mercado del vitíligo se valoró en USD 1.127,12 millones en 2021 y se espera que alcance los USD 1.837,54 millones para 2029, registrando una CAGR del 6,30% durante el período de pronóstico de 2022 a 2029. El informe de mercado curado por el equipo de Data Bridge Market Research incluye un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Definición de mercado

El vitíligo es un trastorno de la piel en el que aparecen manchas incoloras en la piel. El vitíligo puede afectar a toda la superficie de la piel. Esta enfermedad cutánea afecta a los ojos, el interior de la boca y el cabello, y varía de una persona a otra. Es difícil decir hasta dónde se extenderán las manchas y en qué medida. La aparición de manchas o manchas blancas en la piel es el síntoma más común del vitíligo. El vitíligo segmentario y el no segmentario son los dos tipos principales de vitíligo. Los inhibidores de la calcineurina, los corticosteroides y los psoralenos son algunos de los medicamentos más comunes que recetan los médicos para tratar el vitíligo.

Alcance del informe y segmentación del mercado

Vitiligo Market Dynamics

Drivers

• Increasing prevalence of vitiligo

The rising prevalence of vitiligo is estimated to enhance the market's growth. Its prevalence rate ranges between 0.2% and 4%. Vitiligo is a hypopigmentation skin condition in which the skin loses its colour due to a lack of melanin in the skin cells. It affects all portions of the body's skin and the hair and the inside of the mouth. Vitiligo is a skin condition that is neither life-threatening nor communicable. It affects everyone, regardless of their skin type.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of vitiligo market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the Vitiligo market. Additionally, changing lifestyles of people and rising level of disposable income will result in the expansion of Vitiligo market. The growing importance of aesthetic appeal and increased adoption of cosmetic procedures and other dermatology procedures will propel the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the Vitiligo market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate. 

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the Vitiligo market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the Vitiligo market. Additionally, complications involved with vitiligo such as psychological distress, eye problems, sunburn and hearing loss, and lack of awareness among people will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This vitiligo market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Vitiligo market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Vitiligo market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Vitiligo Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The supply chain slowness hampered the vitiligo market.

Recent Development

• In October 2021, Uniza Group had announced the launch of a novel solution named Vitellus for the management of vitiligo. Vitellus is a unique combination of Greyverse, Melitane, GL 200 & EUK-134 which is considered an advanced new age solution for managing vitiligo. It is lotion that helps in melamine growth and functions on skin pigmentation and hair follicle pigmentation.

Global Vitiligo Market Scope

The Vitiligo market is segmented on the basis of type, treatment, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Segmental Vitiligo
• Non-Segmental Vitiligo
• Others

Treatment

• Medications
  • Immunosuppressive
  • Corticosteroids

Others

• Therapies
  • Light Therapy
  • Depigmentation
  • Others
• Surgery
  • Skin grafting
  • Blister grafting
  • Micropigmentation
  • Others
• Others

Dosage Form

• Oral
• Injectable
• Creams
• Gel
• Ointment
• Others

Route of Administration

• Oral
• Parenteral
• Topical
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Vitiligo Market Regional Analysis/Insights

The vitiligo market is analysed and market size insights and trends are provided by country, type, treatment, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the vitiligo market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the vitiligo market because of the favourable reimbursement scenario and presence of major key players in this region. Additionally, rising healthcare expenditure will further propel the market's growth rate in this region.

Asia-Pacific is expected to grow during the forecast period due to the increasing number of cases of skin diseases due to sunlight exposure in this region. Also, development of healthcare infrastructure and rising awareness about the diseases will further propel the market's growth rate in this region.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas abajo y aguas arriba, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.   

Análisis del panorama competitivo y la cuota de mercado del vitíligo

El panorama competitivo del mercado del vitíligo proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado del vitíligo.

Algunos de los principales actores que operan en el mercado del vitíligo son:

• F. Hoffmann-La Roche Ltd. (Suiza)
• Mylan NV (Estados Unidos)
• Industrias farmacéuticas Teva Ltd. (Israel)
• Sanofi (Francia)
• Pfizer Inc. (Estados Unidos)
• GlaxoSmithKline plc (Reino Unido)
• Novartis AG (Suiza)
• Zydus Cadila (India)
• AstraZeneca (Reino Unido)
• Johnson & Johnson (Estados Unidos)
• Bayer AG (Alemania)
• Industrias farmacéuticas Sun Ltd. (India)
• Compañía Bristol-Myers Squibb (Estados Unidos)
• Eli Lilly and Company (Estados Unidos)
• Cipla Inc. (Estados Unidos)
• LEO Pharma A/S (Dinamarca)
• Aurobindo Pharma (India)
• Lupino (India)
• Hikma Pharmaceuticals PLC (Reino Unido)

SKU-54216